JP2007500133A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007500133A5 JP2007500133A5 JP2006521306A JP2006521306A JP2007500133A5 JP 2007500133 A5 JP2007500133 A5 JP 2007500133A5 JP 2006521306 A JP2006521306 A JP 2006521306A JP 2006521306 A JP2006521306 A JP 2006521306A JP 2007500133 A5 JP2007500133 A5 JP 2007500133A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- buprenorphine
- kit
- kit according
- containing transdermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 claims 16
- 229960001736 buprenorphine Drugs 0.000 claims 16
- 239000006211 transdermal dosage form Substances 0.000 claims 11
- 239000002552 dosage form Substances 0.000 claims 10
- 208000004550 Postoperative Pain Diseases 0.000 claims 7
- 238000001356 surgical procedure Methods 0.000 claims 7
- 206010019909 Hernia Diseases 0.000 claims 1
- 230000036592 analgesia Effects 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 238000009802 hysterectomy Methods 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 229940100640 transdermal system Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49036303P | 2003-07-25 | 2003-07-25 | |
| US60/490,363 | 2003-07-25 | ||
| PCT/US2004/024009 WO2005011578A2 (en) | 2003-07-25 | 2004-07-26 | Preoperative treatment of post operative pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007500133A JP2007500133A (ja) | 2007-01-11 |
| JP2007500133A5 true JP2007500133A5 (enExample) | 2007-05-10 |
| JP5632573B2 JP5632573B2 (ja) | 2014-11-26 |
Family
ID=34115386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521306A Expired - Fee Related JP5632573B2 (ja) | 2003-07-25 | 2004-07-26 | 術後痛の術前治療 |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US20080026042A1 (enExample) |
| EP (1) | EP1638492B1 (enExample) |
| JP (1) | JP5632573B2 (enExample) |
| KR (4) | KR20080011248A (enExample) |
| CN (1) | CN1829489B (enExample) |
| AT (1) | ATE382354T1 (enExample) |
| AU (1) | AU2004261181B2 (enExample) |
| BR (1) | BRPI0412924A (enExample) |
| CA (1) | CA2529983C (enExample) |
| CY (1) | CY1107352T1 (enExample) |
| DE (1) | DE602004011055T2 (enExample) |
| DK (1) | DK1638492T3 (enExample) |
| EA (1) | EA009213B1 (enExample) |
| ES (1) | ES2299871T3 (enExample) |
| GE (1) | GEP201606538B (enExample) |
| HR (1) | HRP20080146T3 (enExample) |
| IL (1) | IL173345A (enExample) |
| IS (1) | IS8186A (enExample) |
| MA (1) | MA28005A1 (enExample) |
| MX (1) | MXPA06000990A (enExample) |
| NO (1) | NO326636B1 (enExample) |
| NZ (1) | NZ594154A (enExample) |
| PL (1) | PL1638492T3 (enExample) |
| PT (1) | PT1638492E (enExample) |
| UA (1) | UA81689C2 (enExample) |
| WO (1) | WO2005011578A2 (enExample) |
| ZA (1) | ZA200510071B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| DE10361306A1 (de) * | 2003-12-24 | 2005-07-28 | Lts Lohmann Therapie-Systeme Ag | Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür |
| JP2011251944A (ja) * | 2010-06-02 | 2011-12-15 | Kansai Medical Univ | 埋植用鎮痛製剤 |
| DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
| ES2688577T3 (es) | 2010-09-03 | 2018-11-05 | Zoetis Belgium S.A. | Composiciones de buprenorfina en dosis altas y uso como analgésico |
| RU2459640C2 (ru) * | 2010-10-26 | 2012-08-27 | Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" | Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией |
| RU2487734C1 (ru) * | 2011-11-17 | 2013-07-20 | Анатолий Анатольевич Лаврентьев | Способ послеоперационного обезболивания |
| RU178867U1 (ru) * | 2016-05-04 | 2018-04-20 | Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" | Вакуумная микроразмерная кристаллизационная ячейка |
| RU2649961C1 (ru) * | 2017-02-28 | 2018-04-05 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) | Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела |
| WO2024055006A2 (en) * | 2022-09-09 | 2024-03-14 | The Regents Of The University Of California | Compositions for preventing transition from acute to chronic pain |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4119713A (en) * | 1977-02-09 | 1978-10-10 | Sam Carosio | Analgesic and anti-inflammatory composition |
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| US5026556A (en) * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
| US5240711A (en) * | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
| DK0484543T3 (da) * | 1990-04-24 | 1996-01-22 | Teijin Ltd | Plaster |
| US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
| SE9003665D0 (sv) * | 1990-11-16 | 1990-11-16 | Kabivitrum Ab | Morphine prodrugs |
| JP2669951B2 (ja) * | 1991-03-28 | 1997-10-29 | 雍憲 森本 | 麻薬性鎮痛剤を含有する経皮吸収組成物 |
| US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| CA2174803C (en) * | 1996-04-23 | 2000-07-11 | Jonathan P. Wong | Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug |
| JPH1036265A (ja) * | 1996-07-19 | 1998-02-10 | Nitto Denko Corp | ブプレノルフィン経皮吸収製剤 |
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US5942530A (en) * | 1997-08-28 | 1999-08-24 | Eli Lilly And Company | Method for treating pain |
| KR100383252B1 (ko) * | 1998-12-17 | 2003-07-16 | 주식회사 삼양사 | 부프레놀핀을함유하는경피투여조성물및이를포함하는패취 |
| DE19901085C2 (de) * | 1999-01-14 | 2003-12-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps |
| JP4659943B2 (ja) * | 2000-02-25 | 2011-03-30 | 帝三製薬株式会社 | 塩酸ブプレノルフィン含有貼付剤 |
| AU2001262683A1 (en) * | 2000-06-02 | 2001-12-17 | Teijin Limited | Buprenorphine-containing patch |
| GB0026137D0 (en) * | 2000-10-25 | 2000-12-13 | Euro Celtique Sa | Transdermal dosage form |
| US20020106407A1 (en) * | 2000-12-11 | 2002-08-08 | Dennis Coleman | Method and apparatus for treating breakthrough pain |
| DK2113315T3 (da) * | 2001-04-23 | 2014-08-18 | Euro Celtique Sa | Bortskaffelsessystem til transdermal doseringsform |
| PT2062573E (pt) * | 2001-05-01 | 2012-01-11 | Euro Celtique Sa | Sistemas transdérmicos que contêm opióides que resistem a violação |
| DE60235159D1 (de) * | 2001-05-22 | 2010-03-11 | Euro Celtique Sa | Behälter und verfahren zum abgeben transdermaler dosierungsformen |
| MXPA05006334A (es) * | 2002-12-13 | 2005-08-26 | Euro Celtique Sa | Dosis de buprenorfina transdermica para analgesia. |
-
2004
- 2004-07-26 AU AU2004261181A patent/AU2004261181B2/en not_active Ceased
- 2004-07-26 PL PL04779185T patent/PL1638492T3/pl unknown
- 2004-07-26 GE GEAP20049183A patent/GEP201606538B/en unknown
- 2004-07-26 KR KR1020087001559A patent/KR20080011248A/ko not_active Ceased
- 2004-07-26 JP JP2006521306A patent/JP5632573B2/ja not_active Expired - Fee Related
- 2004-07-26 AT AT04779185T patent/ATE382354T1/de active
- 2004-07-26 BR BRPI0412924-5A patent/BRPI0412924A/pt not_active Application Discontinuation
- 2004-07-26 ES ES04779185T patent/ES2299871T3/es not_active Expired - Lifetime
- 2004-07-26 KR KR1020067001687A patent/KR20060054346A/ko not_active Ceased
- 2004-07-26 EA EA200600284A patent/EA009213B1/ru not_active IP Right Cessation
- 2004-07-26 EP EP04779185A patent/EP1638492B1/en not_active Expired - Lifetime
- 2004-07-26 KR KR1020097005038A patent/KR20090031961A/ko not_active Withdrawn
- 2004-07-26 NZ NZ594154A patent/NZ594154A/xx not_active IP Right Cessation
- 2004-07-26 MX MXPA06000990A patent/MXPA06000990A/es active IP Right Grant
- 2004-07-26 HR HR20080146T patent/HRP20080146T3/xx unknown
- 2004-07-26 DE DE602004011055T patent/DE602004011055T2/de not_active Expired - Lifetime
- 2004-07-26 PT PT04779185T patent/PT1638492E/pt unknown
- 2004-07-26 WO PCT/US2004/024009 patent/WO2005011578A2/en not_active Ceased
- 2004-07-26 KR KR1020127027106A patent/KR20120128715A/ko not_active Ceased
- 2004-07-26 DK DK04779185T patent/DK1638492T3/da active
- 2004-07-26 US US10/566,056 patent/US20080026042A1/en not_active Abandoned
- 2004-07-26 CA CA2529983A patent/CA2529983C/en not_active Expired - Fee Related
- 2004-07-26 UA UAA200602137A patent/UA81689C2/ru unknown
- 2004-07-26 CN CN2004800215648A patent/CN1829489B/zh not_active Expired - Fee Related
-
2005
- 2005-12-12 ZA ZA200510071A patent/ZA200510071B/en unknown
- 2005-12-19 IS IS8186A patent/IS8186A/is unknown
-
2006
- 2006-01-24 IL IL173345A patent/IL173345A/en not_active IP Right Cessation
- 2006-02-23 MA MA28831A patent/MA28005A1/fr unknown
- 2006-02-24 NO NO20060912A patent/NO326636B1/no not_active IP Right Cessation
-
2008
- 2008-03-21 CY CY20081100328T patent/CY1107352T1/el unknown
-
2010
- 2010-09-13 US US12/880,952 patent/US20110002975A1/en not_active Abandoned
-
2014
- 2014-01-07 US US14/149,622 patent/US20140221413A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1571656B (zh) | 利多卡因在制备用于治疗非神经病性疼痛的透皮贴剂中的用途 | |
| WO2005091991A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders | |
| RU2001128504A (ru) | Композиции для стимулирования роста | |
| EA200600820A1 (ru) | Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина | |
| KR101514414B1 (ko) | 당뇨병성 족부 궤양의 치료방법 | |
| JP2005506995A5 (enExample) | ||
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| JP2006516571A5 (enExample) | ||
| JP2007500133A5 (enExample) | ||
| WO2009022338A3 (en) | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications | |
| WO2003073981A3 (en) | Novel of cytokine inhibitors | |
| EP1348466A3 (en) | Method for treating pain with adenosine-tetraphosphates | |
| CY1107352T1 (el) | Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου | |
| JP2004537500A5 (enExample) | ||
| CA2541813A1 (en) | Methods for treating acute and overuse sprain and strain using hyaluronic acid | |
| TW200420290A (en) | Methods for the treatment, prevention and management of macular degeneration | |
| JP2017537067A5 (enExample) | ||
| JP2010519192A5 (enExample) | ||
| CN101631550A (zh) | 带状疱疹后神经痛治疗用片剂以及带状疱疹后神经痛的治疗方法 | |
| JPH08505402A (ja) | 粘膜表皮性及び表皮性の痛み、炎症及び感染症の治療方法及び治療用組成物 | |
| NO982935L (no) | Hyaluronsyre reseptor bindemiddel og anvendelse derav | |
| JP2003055205A (ja) | 抗真菌病組成物 | |
| CN1750831A (zh) | 痔疮治疗剂 | |
| JPH08268884A (ja) | 敗血病性ショックの治療に有用な医薬組成物ならびに解熱および抗炎症医薬組成物を調製するための６，７−置換−２−アミノテトラリンの使用 | |
| BR0314959A (pt) | Emplastro transdérmico de 17beta-estradiol/levonorgestrel para terapia de reposição hormonal |